KX Innovation Balance Sheet Health
Financial Health criteria checks 2/6
KX Innovation has a total shareholder equity of ₩339.0B and total debt of ₩206.3B, which brings its debt-to-equity ratio to 60.9%. Its total assets and total liabilities are ₩1,038.5B and ₩699.6B respectively. KX Innovation's EBIT is ₩61.6B making its interest coverage ratio 2.8. It has cash and short-term investments of ₩148.9B.
Key information
60.9%
Debt to equity ratio
₩206.27b
Debt
Interest coverage ratio | 2.8x |
Cash | ₩148.89b |
Equity | ₩338.98b |
Total liabilities | ₩699.57b |
Total assets | ₩1.04t |
Recent financial health updates
Recent updates
KX Innovation's (KOSDAQ:122450) Earnings Seem To Be Promising
May 29Here's Why KMH (KOSDAQ:122450) Can Manage Its Debt Responsibly
Apr 19Return Trends At KMH (KOSDAQ:122450) Aren't Appealing
Mar 29Do Institutions Own KMH Co. Ltd. (KOSDAQ:122450) Shares?
Mar 11KMH Co. Ltd.'s (KOSDAQ:122450) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Feb 18Announcing: KMH (KOSDAQ:122450) Stock Increased An Energizing 190% In The Last Year
Feb 01The Attractive Combination That Could Earn KMH Co. Ltd. (KOSDAQ:122450) A Place In Your Dividend Portfolio
Jan 14Here's Why We Think KMH (KOSDAQ:122450) Is Well Worth Watching
Dec 30KMH (KOSDAQ:122450) Is Growing Earnings But Are They A Good Guide?
Dec 12Do Institutions Own KMH Co. Ltd. (KOSDAQ:122450) Shares?
Nov 24Financial Position Analysis
Short Term Liabilities: A122450's short term assets (₩246.1B) do not cover its short term liabilities (₩317.4B).
Long Term Liabilities: A122450's short term assets (₩246.1B) do not cover its long term liabilities (₩382.2B).
Debt to Equity History and Analysis
Debt Level: A122450's net debt to equity ratio (16.9%) is considered satisfactory.
Reducing Debt: A122450's debt to equity ratio has increased from 29% to 60.9% over the past 5 years.
Debt Coverage: A122450's debt is well covered by operating cash flow (47.7%).
Interest Coverage: A122450's interest payments on its debt are not well covered by EBIT (2.8x coverage).